Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
8,587
Total Claims
$1.0M
Drug Cost
356
Beneficiaries
$2,932
Cost/Patient
Risk Score Breakdown 3/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
+108%
Cost per patient vs peers
$2,932 vs $1,411 avg
+41%
Brand preference vs peers
15.0% vs 10.6% avg
Brand vs Generic
Brand: 1,231 claims · $834K
Generic: 6,978 claims · $198K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Sitagliptin Phosphate | 123 | $208K |
| Empagliflozin | 76 | $144K |
| Sacubitril/Valsartan | 42 | $66K |
| Insulin Aspart | 87 | $53K |
| Insulin Glargine,hum.Rec.Anlog | 93 | $47K |
| Apixaban | 56 | $43K |
| Budesonide/Formoterol Fumarate | 88 | $42K |
| Dulaglutide | 26 | $35K |
| Rivaroxaban | 17 | $18K |
| Lactulose | 19 | $17K |
| Insulin Glargine,hum.Rec.Anlog | 25 | $17K |
| Albuterol Sulfate | 398 | $14K |
| Fluticasone Propion/Salmeterol | 27 | $13K |
| Fluticasone Propion/Salmeterol | 19 | $11K |
| Atorvastatin Calcium | 601 | $11K |
Prescribing Profile
Patient Profile
71
Avg Age
57%
Female
1.67
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data